Purchase Order HHSF223201610173P

This federal contract award is for the ROKA ATLAS SYSTEM, a purchase order contract valued at $82,808.17 awarded to Rokabio Inc., a for-profit, woman-owned manufacturer of medical diagnostics and analytical laboratory instruments. The contract, which has a firm fixed price and ultimate completion date of August 16, 2024, was awarded on July 4, 2019 by the Food and Drug Administration, a civilian agency. The contract does not have a set-aside designation. Rokabio Inc., doing business as Roka...

This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Rokabio Inc., doing business as Roka Bioscience, a for-profit, woman-owned manufacturer of medical devices and assay reagents. The $160,699.00 contract funds the delivery of the company's specialized EG2 STEC assay kits and related consumables, including reagents, controls, transfer tubes, and other ancillary items, to support the Department of Defense's Food Analysis and Diagnostic Laboratory...

This federal contract award to Rokabio Inc., doing business as Roka Bioscience, is a firm fixed price purchase order from the Department of the Army Medical Command. The $194,785.00 contract is for the delivery of 250 EG2 Combo STEC assays, which are specialized medical devices used to rapidly detect dangerous E.coli strains. Rokabio, a for-profit, woman-owned manufacturer, has provided similar medical devices, assays, reagents, and support services to the Department of Defense through past...

This is a purchase order contract awarded by the Defense Health Agency (DHA) to Rokabio Inc., doing business as Roka Bioscience, a for-profit, woman-owned manufacturer of medical diagnostics and analytical laboratory instruments. The $85,343.78 firm-fixed-price contract is for the delivery of EG2 Combo Shiga toxin-producing E. coli (STEC) assay kits and associated maintenance services to support the Department of Defense's Food Analysis and Diagnostic Laboratory (FADL) at military...

This firm fixed-price purchase order was awarded by the Department of the Army Medical Command to Rokabio Inc., doing business as Roka Bioscience, a for-profit, woman-owned manufacturer of medical devices and assays. The contract, valued at $122,850.00, is for the delivery of EG2 Combo STEC Assay kits, which are used to test for dangerous E.coli strains. Rokabio has previously provided the Army and other DoD agencies with automated molecular detection instruments, assay reagents, and...

<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Biogx, Inc., a small business manufacturer, for preventative maintenance of SmartCycler equipment. The contract has a total ceiling value of $124,397.28 and a completion date of September 28, 2014. The contract was set aside for small businesses.</p>

<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Bioproximity LLC, a for-profit limited liability company, for global proteomic profiling sample preparation and data services. The contract has a ceiling value of $89,100.00 and an ultimate completion date of August 2, 2016. This contract award is not associated with a larger vehicle and does not have a set-aside designation.</p>

<p>Rokabio Inc., doing business as Roka Bioscience, has been awarded a $195,505 firm fixed price purchase order by the Defense Health Agency to deliver the PRT-1398 EG2COMBO STEC assay. The contract has no set-aside designation and requires completion of the assay by September 30, 2023. Roka Bioscience will perform the contract from its location in Fort Sam Houston, Texas to support the Defense Health Agency's medical product needs. No major subcontractors were identified.</p>

This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Kaiser Optical Systems, Inc., a for-profit manufacturer of goods. The contract is for the delivery of a portable standalone Raman instrument, with a ceiling value of $214,001.00 and a performance period ending on March 1, 2021. The contract does not have a set-aside designation. No additional information about subcontractors or the agency's specific programs is...

<p>This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Applied Nanofluorescence, LLC, a small disadvantaged business, for the repair and preventative maintenance (PM) services of a NANOSPECTRALYZER SYSTEM. The contract has a ceiling value of $12,680.04 and an ultimate completion date of July 31, 2023. The contract was set aside for a total small business.</p>